NCT06118463View on ClinicalTrials.gov

Study on AUNIP as a Novel Tumor Marker for Cervical Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

October 1, 2027

Study Completion Date

January 1, 2029

Conditions
Cervical Cancer
Interventions
DIAGNOSTIC_TEST

Detection of serum AUNIP expression

The experiment is carried out according to the ELISA kit instructions, and the absorbance optic density (OD) value of the enzyme labeler at 450 nm is read. The protein concentration of AUNIP in the serum sample is calculated according to the standard curve.

All Listed Sponsors
lead

Lin Yuan

OTHER

NCT06118463 - Study on AUNIP as a Novel Tumor Marker for Cervical Cancer | Biotech Hunter | Biotech Hunter